Key result
Early steroid pulse therapy did not significantly reduce the rate of unfavorable neurologic outcomes or in-hospital mortality compared to no early steroid therapy among children with influenza virus-associated encephalopathy (13.7% vs 8.3%, p=0.16).
Why the study?
Steroid pulse therapy might benefit some clinical subtypes of influenza virus-associated encephalopathy if given early, but early identification of responsive patients is difficult and its effectiveness remained unclear.
Does early steroid pulse therapy improve outcomes in children with influenza virus-associated encephalopathy?
Observational (n=692)
Yes
Does early steroid pulse therapy improve outcomes in children with influenza virus-associated encephalopathy?
Absolute Event Rate: 13.7% vs 8.3%
p-value: p=0.16
Early steroid pulse therapy did not significantly reduce unfavorable outcomes or in-hospital mortality among children with influenza virus-associated encephalopathy.
Early steroids not linked to better outcomes in pediatric influenza encephalopathy; leaves open need for RCTs.
Background Influenza virus-associated encephalopathy (IAE) can lead to neurological sequela and mortality among children. Therefore, instant recognition and therapeutic intervention for IAE are crucial. In some clinical subtypes of IAE, steroid pulse therapy might be beneficial, especially when it is administered in the early phase. However, early identification of patients who may benefit from steroid pulse therapy is sometimes difficult. We aimed to assess the effectiveness of early steroid pulse therapy among children with IAE. Methods In this retrospective observational study, we used a national database that covers half of the acute care inpatients across Japan to identify inpatients aged ≤ 18 years with a diagnosis of IAE between July 2010 and March 2017. Unfavorable outcome was defined as a composite outcome of sequela including Japan Coma Scale ≥ 10 at discharge, requiring tracheostomy, mechanical ventilation, enteral tube feeding, rehabilitation at discharge, or in-hospital death. Propensity score matching was performed to compare unfavorable outcome and in-hospital mortality between patients with and without steroid pulse therapy within 2 days of admission. Results Among 692 patients included in the study, the mean age was 5.8 years, and 55.8% were male. The overall in-hospital mortality was 1.3%, and the proportion of the unfavorable outcome was 15.0%. We observed no significant difference in the unfavorable outcome between matched patients (168 patients in each group) with and without early steroid pulse therapy (13.7% vs 8.3%;P = 0.16) or in-hospital mortality (0.6% vs 1.2%;P = 1.0). Conclusions We did not observe the effectiveness of early steroid pulse therapy on patient outcomes among children with IAE in our study population including all clinical subtypes of IAE. Further studies considering severity of illness are warranted to determine whether steroid pulse therapy is beneficial, especially for specific clinical subtypes of IAE.
No takes yet. Share an insight, caveat, or question.
Hatachi et al. (2020) conducted an observational in Influenza virus-associated encephalopathy (IAE) (n=692). Early steroid pulse therapy vs. No early steroid pulse therapy was evaluated on Composite unfavorable outcome (neurologic sequela or in-hospital death) (p=0.16). Early steroid pulse therapy did not significantly reduce the rate of unfavorable neurologic outcomes or in-hospital mortality compared to no early steroid therapy among children with influenza virus-associated encephalopathy (13.7% vs 8.3%, p=0.16).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: